Progyny reaffirms FY2022 high-end guidance; expects record Q4 operating cash flow ~$50M

Progyny, Inc.

Q4 and FY2022 revenue, net income, Adj. EBITDA expected at or near high-end of guidance issued Nov 28, 2022.
Record Q4 operating cash flow of ~$50M; full-year ~$79M, reflecting high capital efficiency.
More than 370 clients and 5.4 million covered lives for 2023; substantially all new clients already launched.
Record new client wins in 2022; over 25% of existing clients expanded relationships despite macro environment.
Early 2023 selling season activity very encouraging; family building benefits remain top employer priority.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Progyny, Inc. updated its quarter and year ended December 31, 2022 guidance (reaffirmed).

Period: quarter and year ended December 31, 2022
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

Progyny, Inc. (the “Company”) issued a press release to reaffirm the Company’s previously issued financial guidance for the three months and year ending December 31, 2022.

View on SEC.gov

Browse all earnings releases →

Progyny, Inc. filing history →

Source: SEC EDGAR

accession 0001551306-23-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.